ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.

This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

Utilizing phenotypic screening yield new pain therapeutic candidates
Multi-targeted approaches to pain drug development
Analysis of new drug discovery targets
Clinical trial endpoints in pain
Real-time fMRI (functional magnetic resonance imaging) for pain
Analysis of CGRP antagonist, NGF antagonist, TRP!1 antagonist, Nav 1.7 antagonist, and P2x receptor antagonist clinical development programs
Programmable devices and therapeutics for patient-controlled analgesia
Exploration and analysis of animal models for pain
Abuse-resistant opioid formulations in clinical development
Combination therapy approaches to pain management
Treatment strategies for opioid-induced constipation
Clinical development status of longer-acting analgesics for post-operative pain
Review and analysis of key developmental stage therapies for nociceptive pain, neuropathic pain, migraine, back pain, fibromyalgia, cancer pain, arthritic pain, acute pain and chronic pain
The future role of pharmacogenomics, biomarkers and translational research in the development of therapeutics for pain
An examination of regulatory hurdles facing developers of new pain therapies
Abuse liability and safety issues affecting the developers of opioids
Analysis and case studies of successful commercialization strategies for pain therapies

LEARN about the latest developments and the most recent commercial breakthroughs in the area of pain therapeutics

GAIN a better sense of the impact the biotech industry is having on the development of pain therapeutics

DISCOVER what innovative new therapies are driving investment and clinical development in the area of pain therapeutics

NETWORK with leaders from the pharma, biotech, specialty pharma and drug delivery industries as well as the academic community and government

BETTER UNDERSTAND the specific and implications of groundbreaking new research in the field of pain therapeutics

ACQUIRE a holistic view of the field of pain therapeutics from the perspective of scientists, clinicians and commercial executives